Campbell, H E <br/><br/>
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Nov 2011 
 - 2517-30 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2011.06.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--economics<br/>Antineoplastic Combined Chemotherapy Protocols--economics<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--economics<br/>Cost-Benefit Analysis<br/>Cyclophosphamide--economics<br/>Docetaxel<br/>Epirubicin--economics<br/>Female<br/>Fluorouracil--economics<br/>Health Care Costs<br/>Humans<br/>Methotrexate--economics<br/>Middle Aged<br/>Prognosis<br/>Quality-Adjusted Life Years<br/>Taxoids--economics